Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Obesity Drugs Gain Attention on FDA Backing for Therapies
Obesity Drugs Gain Attention on FDA Backing for Therapies
Obesity Drugs Gain Attention on FDA Backing for Therapies
Submitted by
admin
on September 19, 2012 - 10:53am
Source:
Bloomberg
News Tags:
FDA
obesity
Zafgen
beloranib
Arena Pharmaceuticals
Headline:
Obesity Drugs Gain Attention on FDA Backing for Therapies
Do Not Allow Advertisers to Use My Personal information
